AUSTIN, Texas, June 7, 2017 /PRNewswire/ — Savara Inc. (NASDAQ: SVRA), a clinical-stage specialty pharmaceutical company focused on the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases, today announced the…
June 08, 2017 at 02:06AM
from
No comments:
Post a Comment